Virginia Apgar kept score for America’s babies and coveted scores on the violin as well. She was a doctor, musician, instrument maker — and an overall pioneering female physician who overcame the prejudices of her era to forge a profound legacy for humanity. Dr. Apgar is the namesake of a …
Read More »
The first artificial intelligence (AI) stethoscope has gone beyond listening to a heartbeat. Researchers at Imperial College London and Imperial College Healthcare NHS Trust discovered that an AI stethoscope can detect heart failure at an early stage. The TRICORDER study results, published in BMJ Journals, found that the AI-enabled stethoscope …
Read More »
Levels of iron in the brain could be a warning sign of future Alzheimer’s disease, a new study suggests. High levels of the chemical element have been shown to increase brain toxins and trigger neurodegeneration, resulting in cognitive decline — especially when they interact with theabnormal amyloid and tau proteins …
Read More »
A common vitamin could help prevent the development of skin cancer, new research suggests. The study, published in JAMA Dermatology, found a decreased risk of three types of skin cancer associated with the use of nicotinamide, which is a form of vitamin B3. The research examined the health data of …
Read More »
The U.S. Food and Drug Administration has approved a new treatment for advanced breast cancer. Drugmaker Eli Lilly announced Sept. 25 the approval of Inluriyo, an oral estrogen receptor antagonist, to treat adults with specific types of the disease. Those types include estrogen receptor-positive (ER+), human epidermal growth factor receptor …
Read More »
A Washington man appeared to be destined to develop Alzheimer’s disease — but against all genetic odds, he has eluded the common dementia for decades. Researchers at the Washington University School of Medicine in St. Louis recently published a study focusing on Doug Whitney, 76, who lives near Seattle. He …
Read More »
An experimental drug could help to improve movement for patients with spinal cord injuries. NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom noted remarkable outcomes. Larry Williams, a trial participant based in Philadelphia, Pennsylvania, shared with Fox News Digital …
Read More »
A new treatment strategy tested by UCLA researchers could offer new hope for men whose prostate cancer has returned after initial treatment. This approach could also help delay the need for hormone therapy, which can have burdensome side effects. The findings, which were presented at the annual American Society for …
Read More »
A groundbreaking international study has uncovered striking genetic differences in how women and men experience depression, and it could help explain why women are diagnosed with the condition at nearly double the rate of men. SKIN DNA BREAKTHROUGH COULD LET 60-YEAR-OLD WOMEN HAVE GENETICALLY RELATED KIDS The research, published in …
Read More »
Scientists may have discovered the first therapy for Huntington’s disease, a brain disorder that until now has had no effective treatments. Researchers at the University of College London (UCL) announced positive results from a global clinical trial for a new gene therapy, AMT-130. Developed by the Dutch biotechnology company uniQure, …
Read More »